These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32873192)

  • 1. No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19.
    Jones GW; Monopoli MP; Campagnolo L; Pietroiusti A; Tran L; Fadeel B
    Nanomedicine (Lond); 2020 Oct; 15(24):2411-2427. PubMed ID: 32873192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
    Pang X; Cui Y; Zhu Y
    Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.
    Poduri R; Joshi G; Jagadeesh G
    Cell Signal; 2020 Oct; 74():109721. PubMed ID: 32711111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.
    Zhao X; Jiang Y; Zhao Y; Xi H; Liu C; Qu F; Feng X
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1209-1220. PubMed ID: 32328850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology versus coronavirus.
    Nat Nanotechnol; 2020 Aug; 15(8):617. PubMed ID: 32764720
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection.
    Goyal RK; Majeed J; Tonk R; Dhobi M; Patel B; Sharma K; Apparsundaram S
    Rev Cardiovasc Med; 2020 Sep; 21(3):365-384. PubMed ID: 33070542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 and the cardiovascular system.
    Hafiane A
    Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 14. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
    Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
    Wu L; O'Kane AM; Peng H; Bi Y; Motriuk-Smith D; Ren J
    Biochem Pharmacol; 2020 Aug; 178():114114. PubMed ID: 32579957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.
    Rao L; Xia S; Xu W; Tian R; Yu G; Gu C; Pan P; Meng QF; Cai X; Qu D; Lu L; Xie Y; Jiang S; Chen X
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27141-27147. PubMed ID: 33024017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
    Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
    Ballout RA; Sviridov D; Bukrinsky MI; Remaley AT
    FASEB J; 2020 Jun; 34(6):7253-7264. PubMed ID: 32367579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.